Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms

Infection and Immunity

Volumn 77, Issue 7, 2009, Pages 2813-2823

  Shimizu, Takeshi ^a   Ohta, Yuko ^a   Noda, Masatoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE; VEROTOXIN 1; VEROTOXIN 2;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; CELL FRACTIONATION; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION;

ANIMALS; BACTERIOLYSIS; COLIPHAGES; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENES, VIRAL; PROPHAGES; PROTEIN TRANSPORT; RABBITS; SHIGA TOXIN 2;

EID: 67650021448     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00060-09     Document Type: Article

References (52)

1. Acheson, D. W. K., A. Donohue-Rolfe, and G. T. Keusch. 1991. The family of Shiga and Shiga-like toxins, p. 415-433. In J. E. Alouf, and J. H. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press Ltd., London, United Kingdom.
2. 1 transcriptional fusion to gfp FEMS Microbiol. Lett. 245:73-77.
3. Bläsi, U., and R. Young. 1996. Two beginnings for a single purpose: the dual-start holins in the regulation of phage lysis. Mol. Microbiol. 21:675-682.
4. Calderwood, S. B., F. Auclair, A. Donohue-Rolfe, G. T. Keusch, and J. J. Mekalanos. 1987. Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc. Natl. Acad. Sci. USA 84:4364-4368.
5. Calderwood, S. B., and J. J. Mekalanos. 1987. Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J. Bacteriol. 169:4759-4764.
6. Datz, M., C. Janetzki-Mittmann, S. Franke, F. Gunzer, H. Schmidt, and H. Karch. 1996. Analysis of the enterohemorrhagic Escherichia coli O157 DNA region containing lambdoid phage gene p and Shiga-like toxin structural genes. Appl. Environ. Microbiol. 62:791-797.
7. De Grandis, S., J. Ginsberg, M. Toone, S. Climie, J. Friesen, and J. Brunton. 1987. Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. J. Bacteriol. 169:4313-4319.
8. Elliott, S. J., and J. B. Kaper. 1997. Role of type 1 fimbriae in EPEC infections. Microb. Pathog. 23:113-118.
9. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:45-50.
10. Fraser, M. E., M. Fujinaga, M. M. Cherney, A. R. Melton-Celsa, E. M. Twiddy, A. D. O'Brien, and M. N. James. 2004. Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J. Biol. Chem. 279:27511-27517.
11. Friedman, D. I., and D. L. Court. 1995. Transcription antitermination: the lambda paradigm updated. Mol. Microbiol. 18:191-200.
12. Fuchs, S., I. Muhldorfer, A. Donohue-Rolfe, M. Kerenyi, L. Emody, R. Alexiev, P. Nenkov, and J. Hacker. 1999. Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens. Microb. Pathog. 27:13-23.
13. Griffin, P. M., S. M. Ostroff, R. V. Tauxe, K. D. Greene, J. G. Wells, J. H. Lewis, and P. A. Blake. 1988. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann. Intern. Med. 109:705-712.
14. Reference deleted.
15. Hofmann, S. L. 1993. Southwestern Internal Medicine Conference: Shigalike toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura. Am. J. Med. Sci. 306:398-406.
16. Huang, A., J. Friesen, and J. L. Brunton. 1987. Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli. J. Bacteriol. 169:4308-4312.
17. Hull, A. E., D. W. Acheson, P. Echeverria, A. Donohue-Rolfe, and G. T. Keusch. 1993. Mitomycin immunoblot colony assay for detection of Shigalike toxin-producing Escherichia coli in fecal samples: comparison with DNA probes. J. Clin. Microbiol. 31:1167-1172.
18. Jackson, M. P., J. W. Newland, R. K. Holmes, and A. D. O'Brien. 1987. Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb. Pathog. 2:147-153.
19. Johansen, B. K., Y. Wasteson, P. E. Granum, and S. Brynestad. 2001. Mosaic structure of Shiga-toxin-2-encoding phages isolated from Escherichia coli O157:H7 indicates frequent gene exchange between lambdoid phage genomes. Microbiology 147:1929-1936.
20. Karch, H., H. Schmidt, C. Janetzki-Mittmann, J. Scheef, and M. Kroger. 1999. Shiga toxins even when different are encoded at identical positions in the genomes of related temperate bacteriophages. Mol. Gen. Genet. 262:600-607.
21. Keusch, G. T., and D. W. Acheson. 1997. Thrombotic thrombocytopenic purpura associated with Shiga toxins. Semin. Hematol. 34:106-116.
22. Lansbury, L. E., and H. Ludlam. 1997. Escherichia coli O157: lessons from the past 15 years. J. Infect. 34:189-193.
23. Lathem, W. W., T. E. Grys, S. E. Witowski, A. G. Torres, J. B. Kaper, P. I. Tarr, and R. A. Welch. 2002. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol. Microbiol. 45:277-288.
24. Little, J. W. 1995. The SOS regulatory system, p. 453-479. In E. C. C. Lin and A. S. Lynch (ed.), Regulation of gene expression in Escherichia coli. R. G. Landis, Georgetown, TX.
25. Livny, J., and D. I. Friedman. 2004. Characterizing spontaneous induction of Stx encoding phages using a selectable reporter system. Mol. Microbiol. 51:1691-1704.
26. Martinez-Morales, F., A. C. Borges, A. Martinez, K. T. Shanmugam, and L. O. Ingram. 1999. Chromosomal integration of heterologous DNA in Escherichia coli with precise removal of markers and replicons used during construction. J. Bacteriol. 181:7143-7148.
27. Neely, M. N., and D. I. Friedman. 1998. Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol. Microbiol. 28:1255-1267.
28. Noda, M., T. Yutsudo, N. Nakabayashi, T. Hirayama, and Y. Takeda. 1987. Purification and some properties of Shiga-like toxin from Escherichia coli 0157:H7 that is immunologically identical to Shiga toxin. Microb. Pathog. 2:339-349.
29. O'Brien, A. D., and R. K. Holmes. 1987. Shiga and Shiga-like toxins. Microbiol. Rev. 51:206-220.
30. O'Brien, A. D., J. W. Newland, S. F. Miller, R. K. Holmes, H. W. Smith, and S. B. Formal. 1984. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 226:694-696.
31. Perna, N. T., G. Plunkett III, V. Burland, B. Mau, J. D. Glasner, D. J. Rose, G. F. Mayhew, P. S. Evans, J. Gregor, H. A. Kirkpatrick, G. Posfai, J. Hackett, S. Klink, A. Boutin, Y. Shao, L. Miller, E. J. Grotbeck, N. W. Davis, A. Lim, E. T. Dimalanta, K. D. Potamousis, J. Apodaca, T. S. Anantharaman, J. Lin, G. Yen, D. C. Schwartz, R. A. Welch, and F. R. Blattner. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409:529-533.
32. Plunkett, G., III, D. J. Rose, T. J. Durfee, and F. R. Blattner. 1999. Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product. J. Bacteriol. 181:1767-1778.
33. Ptashne, M. 1992. A genetics swith, 2nd ed. Cell Press, Blackwell Scientific Publications, Cambridge, MA.
34. Sato, T., T. Shimizu, M. Watarai, M. Kobayashi, S. Kano, T. Hamabata, Y. Takeda, and S. Yamasaki. 2003. Distinctiveness of the genomic sequence of Shiga toxin 2-converting phage isolated from Escherichia coli O157:H7 Okayama strain as compared to other Shiga toxin 2-converting phages. Gene 309:35-48.
35. Sato, T., T. Shimizu, M. Watarai, M. Kobayashi, S. Kano, T. Hamabata, Y. Takeda, and S. Yamasaki. 2003. Genome analysis of a novel Shiga toxin 1 (Stx1)-converting phage which is closely related to Stx2-converting phages but not to other Stx1-converting phages. J. Bacteriol. 185:3966-3971.
36. Shimizu, T., T. Hamabata, A. Yoshiki, T. Hori, S. Ito, Y. Takeda, and H. Hayashi. 2003. An association of 27- and 40-kDa molecules with glycolipids that bind A-B bacterial enterotoxins to cultured cells. Biochim. Biophys. Acta 1612:186-194.
37. Shimizu, T., S. Kawakami, T. Sato, T. Sasaki, M. Higashide, T. Hamabata, T. Ohta, and M. Noda. 2007. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli. Infect. Immun. 75:2189-2200.
38. Stein, P. E., A. Boodhoo, G. J. Tyrrell, J. L. Brunton, and R. J. Read. 1992. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature 355:748-750.
39. Strockbine, N. A., L. R. Marques, J. W. Newland, H. W. Smith, R. K. Holmes, and A. D. O'Brien. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
40. Sung, L. M., M. P. Jackson, A. D. O'Brien, and R. K. Holmes. 1990. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli. J. Bacteriol. 172:6386-6395.
41. Tesh, V. L., and A. D. O'Brien. 1991. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol. Microbiol. 5:1817-1822.
42. Unkmeir, A., and H. Schmidt. 2000. Structural analysis of phage-borne stx genes and their flanking sequences in Shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains. Infect. Immun. 68:4856-4864.
43. Vareille, M., T. de Sablet, T. Hindre, C. Martin, and A. P. Gobert. 2007. Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli. Proc. Natl. Acad. Sci. USA 104:10199-10204.
44. Wagner, P. L., J. Livny, M. N. Neely, D. W. Acheson, D. I. Friedman, and M. K. Waldor. 2002. Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol. Microbiol. 44:957-970.
45. Wagner, P. L., M. N. Neely, X. Zhang, D. W. Acheson, M. K. Waldor, and D. I. Friedman. 2001. Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J. Bacteriol. 183:2081-2085.
46. Wagner, P. L., and M. K. Waldor. 2002. Bacteriophage control of bacterial virulence. Infect. Immun. 70:3985-3993.
47. Waldor, M. K., and J. J. Mekalanos. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910-1914.
48. Weinstein, D. L., M. P. Jackson, L. P. Perera, R. K. Holmes, and A. D. O'Brien. 1989. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity. Infect. Immun. 57:3743-3750.
49. Wu, Y., K. Shima, K. Okazaki, H. Ito, Y. Oyamada, N. Sugimoto, M. Asakura, K. Nishimura, and S. Yamasaki. 2005. Abstr. 40th U.S.-Japan Cholera Other Bacterial Enteric Infect. Joint Panel Meet., abstr. 115-117.
50. Yarnell, W. S., and J. W. Roberts. 1999. Mechanism of intrinsic transcription termination and antitermination. Science 284:611-615.
51. Yoh, M., E. K. Frimpong, and T. Honda. 1997. Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7. FEMS. Immunol. Med. Microbiol. 19:57-64.
52. Yutsudo, T., N. Nakabayashi, T. Hirayama, and Y. Takeda. 1987. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3:21-30.